Deprenyl USA Inc. (NASDAQ:DUSA) of Parsippany, N.J., has filedan investigational new drug (IND) application with FDA for useof its ALA photodynamic therapy (externally applied 5-aminolevulinic acid activated by a light source) for treatingpre-cancerous actinic keratoses and psoriasis.

(c) 1997 American Health Consultants. All rights reserved.

No Comments